Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2020.10.21.348755

Low-frequency subthalamic neural oscillations are involved in explicit and implicit facial emotional processing - a local field potential study

Dondaine, T.·Duprez, J.·Houvenaghel, J.-F.·Modolo, J.·Haegelen, C.·Robert, G.·Millet, B.·Drapier, D.·Verin, M.·Sauleau, P.
View original source ↗Export metadata ↓

Abstract

In addition to the subthalamic nucleus (STN) role in motor control, STN deep brain stimulation (DBS) for Parkinsons disease (PD) has also uncovered its involvement in cognitive and limbic processing. STN neural oscillations analyzed through local field potential (LFP) recordings have been shown to contribute to emotional (mostly in the alpha band [8-12 Hz]) and cognitive processing (theta [4-7 Hz] and beta [13-30 Hz] bands). In this study, we aimed at testing the hypothesis that STN oscillatory activity is involved in explicit and implicit processing of emotions. To achieve this objective, we used a task that presented patients with fearful emotional facial expressions and asked them to identify the emotion (explicit task) or gender associated with the face (implicit task). We evaluated emotion and task effects on STN neural oscillations power and intertrial phase consistency. Our results revealed that accuracy was lower in the implicit task. Increased STN delta power and decreased alpha and beta power were observed after stimulus presentation. However, there was no influence of emotional facial expression, i.e. neutral versus fear, nor task demands. Intertrial phase consistency in the delta and theta band increased after stimulus onset, in the same time-period as delta power increased. However, similarly to oscillatory power, no changes related to emotional fear expression or task demand were found. These findings suggest that STN oscillatory activity is not specifically involved in explicit and/or implicit processing of emotions, and that power and phase synchronization changes might be more related to overall task-execution mechanisms. These conjectures remain to be confirmed. Highlights- STN LFPs were recorded during an emotional/gender recognition task in PD patients. - STN delta power increased, and alpha and beta power decreased after stimulus onset. - Power changes were not influenced by emotional fearful expression or task demands. - Delta/theta intertrial phase consistency increased after stimulus onset. - Intertrial phase consistency was not affected by emotional valence or task demands. - The observed STN activity was likely related to general task-execution mechanisms.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dondaine, T., Duprez, J., Houvenaghel, J.-F., Modolo, J., Haegelen, C., Robert, G., Millet, B., Drapier, D., Verin, M., Sauleau, P.. 2020-10-22. Low-frequency subthalamic neural oscillations are involved in explicit and implicit facial emotional processing - a local field potential study. https://doi.org/10.1101/2020.10.21.348755

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗